| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.9 |